Relates to conversions of real property in public housing developments in relation to the RAD program; sets notice requirements for public housing authorities.
Requires disclosure of both criminal sexual offense convictions and civil liability judgments against physicians to patients when such sexual offenses were committed against patients.
Prohibits the purchase of single-use plastic bottles by the state and any governmental entity or political subdivision or public benefit corporation thereof except for when required by health requirements, emergencies, or when no other alternative is available or practicable.
Prohibits issuance of certain search warrants relating to out-of-state investigations of abortion services provided in NYS; prohibits corporations domiciled in NYS from complying with certain out-of-state search warrants regarding abortion services provided in NYS.
Enacts the "New York state green new deal for public housing act", which commissions a study to assist the state of New York in reaching its climate goals.
Provides for the use of glucagon emergency injection kits by persons other than licensed health care professionals; provides for expanded use of epinephrine auto-injector devices in schools in emergency circumstances.
Relates to fair pricing for low-complexity, routine medical care to more closely align payment rates across ambulatory settings for selected services that are safe and appropriate to provide in all settings.
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
Directs the department of health to develop state food guidelines for foods purchased, served, and sold by state agencies, programs, and institutions and on state property.
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.